drugset / Trial / NCT06713837

Summary

This is a multicenter, randomized, open-label, pragmatic low intervention clinical trial comparing high intensity reinduction chemotherapy with low intensity therapies in 1st or 2nd relapse Acute Myeloid Leukemia. The study is funded by European Commission (HORIZON-MISS-2022-CANCER-01-03, Project ID 101104421)

Timeline

Start
2025-02-27
Primary completion
2028-01
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Azacitidine Other / unclassified — —
Comparator Cladribine Small molecule 5 mg/m2 —
Comparator Cytarabine Small molecule — —
Comparator Daunorubicin Small molecule — —
Subject Decitabine Small molecule — —
Comparator Etoposide Small molecule — —
Comparator Fludarabine Small molecule — —
Subject Gemtuzumab Monoclonal antibody — —
Subject Gilteritinib Small molecule — —
Subject Glasdegib Small molecule — —
Comparator Idarubicin Small molecule — —
Subject Ivosidenib Small molecule — —
Comparator Mitoxantrone Small molecule — —
Subject Venetoclax Small molecule — —